Thomas
Fleming is an intellectual property partner in the New York office of Kirkland
& Ellis LLP. He is a veteran trial lawyer with extensive experience in
complex commercial litigation, intellectual property litigation and patent
litigation. He has co-chaired numerous jury patent trials in the areas of
biotechnology, pharmaceuticals and wireless technology, and has been lead
counsel in patent and trade secret litigation matters in the areas of chemical
products, devices and genetically modified crops. He has argued numerous
appeals, including before the Federal Circuit.
Thomas
advises Fortune 100 companies on intellectual property aspects of international
merger and acquisition matters, licensing and deal related matters. Prior to
joining Kirkland, he litigated matters for DuPont, Pioneer Hi-Bred, Roche,
Genentech, ARIAD Pharmaceuticals and Jarden. He has
also directed several successful trademark and Lanham Act litigations on behalf
of international clients and their U.S. subsidiaries.
Thomas
has been recognized by The Legal 500 U.S. He is
also listed in The Best Lawyers in America and The Best Lawyers in New York. He is a recipient of the 2010 Legal Aid
Society Pro Bono Publico Award.
